AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
BUD
ACCE-researched

Anheuser-Busch Inbev SA Sponsored ADR (Belgium) (BUD) fair value

Consumer Defensive · Beverages - Brewers · NYSE · United States
$84.26-1.44%
Market cap $165.9BNext earnings 2026-10-29Updated Oct 19, 2026
Add earnings to calendarGoogle
Our verdict
Trades 30% above our fair value
Price
$84.26
Model fair valueConfidence: good
$64.82
Model range
$54.69 to $82.42
Fair value $64.82
Price $84.26
5 models fit Anheuser-Busch Inbev SA Sponsored ADR (Belgium) and they partly agree: 3 of 5 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Premium(i)Silver69
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionAnheuser-Busch Inbev SA Sponsored ADR (Belgium) (BUD)
Fair value (5 models)
$64.82
ACCE price target
$84.70
Rating
Overvalued
Horizon
12 months
Fair value published on 19 Oct 2026, 19:04 CEST; previously $63.27 since 11 Oct 2026, 00:00 CEST.
ACCE price target published on 18 Oct 2026, 00:00 CEST; previously $98.40 since 16 May 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 19:04 CEST.
Price used: $84.26 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
30.0% above
-23.1% to fair value
ACCE score
77
out of 100
Analysts
83% buy
12 covering
P/E
18.2x
forward 17.2x
1-year return
+36.8%
Dividend yield
1.57%

Anheuser-Busch Inbev SA Sponsored ADR (Belgium) in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Anheuser-Busch InBev brews Budweiser, Corona, Stella Artois and Michelob Ultra, and sells them through the largest brewing footprint in the world, with a gross margin of 56.5% and an operating margin of 27.3%. Scale in purchasing, distribution and brand equity is the moat here, and it is hard to replicate in a category where a single brand can take decades to build. Revenue grew 11.0% over the period in the data, and premium and international brands are the drivers to watch for the next leg of growth. At 17.5 times trailing earnings and 15.6 times forward, the shares trade at a discount to where the earnings growth profile would suggest, while the 11.4% return on equity points to a business that converts its capital into profit at a solid rate. The company is not in any major index in this dataset, which may mean the name is under-owned by the funds that set many of the flows, and that is the reason it merits a closer read.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • moderate
    Valuation disconnect from model
    EV/EBITDA of 50x is elevated for a mature brewer with 0.9% 5y revenue CAGR.
  • moderate
    Earnings spike sustainability risk
    YoY earnings growth of 124.9% is exceptional for a low-growth business (0.9% 5y CAGR). Likely one-time benefit or accounting; reversion risk is material.
  • moderate
    High leverage with modest FCF yield
    Debt/Equity 0.72 on $152B market cap implies substantial absolute debt. FCF of $10.7B yields only 7% on market cap, limiting deleveraging pace.

AI research notes

AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Recent revenue growth of 11.0% year-over-year shows strong near-term momentum despite a 0.9% five-year average.
  • Free cash flow yield of 7.0% and $10.7B in trailing cash generation support the 1.7% dividend and buybacks.
  • Stock trades at 15.7x forward P/E, below the 18.1x sector median, while 92% of analysts rate it Buy or Strong Buy.
Why it could disappoint
  • Consensus fair value of $63.27 implies the stock is 18.2% overvalued at the current $77.33 price.
  • Return on invested capital of 3.5% and ROE of 11.4% are weak relative to the 5.2% risk-free rate.
  • Five-year revenue growth averaged only 0.9% annually, suggesting limited organic expansion beyond recent cyclical strength.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Oct 29, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where BUD's valuation models land
Price
$84.26
Model fair value
$64.82
Model range
$54.69 to $82.42
Fair value $64.82
Price $84.26
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish83% buy · 12 covering analysts
● Strong buy 7● Buy 3● Hold 2● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
0 buys · 1 sell
Since Aug 18, 2026, 1 member
Average delay
9 days
From trade to public filing
Full trade list on ProDo politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+2.0%
1 month
+9.3%
3 months
+3.2%
6 months
+16.1%
YTD
+31.6%
1 year
+36.8%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
19 Oct 2026, 19:04 CESTRatingOvervaluedfirst publication$82.59
19 Oct 2026, 19:04 CESTFair value$64.82$63.27$82.59
18 Oct 2026, 00:00 CESTACCE price target$84.70$98.40$82.59
11 Oct 2026, 00:00 CESTFair value$63.27$68.52$77.33
7 Oct 2026, 00:00 CESTFair value$68.52$67.44$74.82
1 Oct 2026, 00:00 CESTFair value$67.44$68.66$74.29
28 Sept 2026, 00:00 CESTFair value$68.66$69.84$78.00
19 Sept 2026, 00:00 CESTFair value$69.84$69.11$78.77
17 Sept 2026, 00:00 CESTFair value$69.11$70.03$79.46
14 Sept 2026, 00:00 CESTFair value$70.03$70.99$78.23

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full BUD page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth76Value74Quality69Momentum90Total77
Valuation
Trailing P/E
18.2x
Forward P/E
17.2x
PEG
0.14
P/B
1.62x
EV / Revenue
3.5x
Book value/sh
$7.92
Enterprise value
$216.4B
Profitability
ROE
11.4%
FCF yield
6.95%
ROIC
3.5%
Health and risk
Debt / equity
0.84
Dividend yield
1.57%
Beta
0.78

Price

+37.5% · 1Y

Ask anything about BUD

Answered from Anheuser-Busch Inbev SA Sponsored ADR (Belgium) fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 50% of peers
low 9.2x18.2xhigh 18.9x
ROEbetter than 17% of peers
low 11%11%high 24%
Div yieldbetter than 33% of peers
low 0.0%1.6%high 4.1%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
BUD Anheuser-Busch Inbev SA Sponsored ADR (Belgium)$84.26$6530% above18.2x11.4%6977
ABI.BR Anheuser-Busch InBev€75.82€5929% above18.9x11.4%6978
FEMSAUBD.MX Fomento Economico MexicanoMXN 241.06MXN 15457% above18.7x14.8%6172
ABEV Ambev S.A. American Depositary Shares (Each representing 1 Common Share)$3.33$417% below17.5x18.4%8477
HEIA.AS Heineken€77.90€7110% above18.9x12.1%5967
FMX Fomento Economico Mexicano S.A.B. de C.V. Common Stock$129.03$7181% above9.2x14.8%5670
STZ Constellation Brands Inc. Common Stock$138.98$1465% below12.4x24.0%8264

Sector report card

Where BUD ranks against its sector peers on each metric.

Computing percentiles…
  • PR Newswire•Sep 21, 2026
    Anheuser-Busch Invests $23 Million in Fort Collins, CO Brewery to Drive Local Economic Growth, Expands Local Manufacturing Skills Training
  • PR Newswire•Sep 17, 2026
    Anheuser-Busch Invests $21 Million in Los Angeles, CA Facilities, Expands Local Manufacturing Skills Training
  • Business Wire•Aug 26, 2026
    Netflix and Stella Artois Bring the Perfect Serve to The Gentlemen Season 2
6 more press releases · full archive on Investor+.INVESTOR
16 filings of 34
July 2026
Jul 30
6-KForeign current reportPeriod 2026-06-30
View on SEC →
Jul 30
6-KForeign current reportPeriod 2026-07-30
View on SEC →
June 2026
Jun 16
6-KForeign current reportPeriod 2026-06-16
View on SEC →
13 more filings + AI summaries on Investor+.INVESTOR